Recombinant expression of antimicrobial peptides using a novel self-cleaving aggregation tag in Escherichia coli.
Luan. Chao C; Xie. Yong Gang YG; Pu. Yu Tian YT; Zhang. Hai Wen HW; Han. Fei Fei FF; Feng. Jie J; Wang. Yi Zhen YZ
Key Findings
- A self‑cleaving aggregation tag (ΔI‑CM mini‑intein + 18A peptide) lets LL‑37 be expressed as active aggregates in E. coli
- LL‑37 was recovered by simple centrifugation and intein‑mediated cleavage, yielding ~0.59 ± 0.11 mg/L with antimicrobial activity
- The process uses standard lab steps (culture, centrifugation, cation‑exchange chromatography) and avoids expensive synthetic peptide costs
Practical Outcomes
- If you have basic molecular‑biology skills and access to a shaker incubator, centrifuge, and chromatography setup, you can produce LL‑37 yourself at a fraction of commercial price. The method is straightforward but still requires cloning and purification steps, so it’s most useful for DIY bio labs rather than home‑kitchen setups.
Summary
Scientists made a cheap way to produce the immune‑boosting peptide LL‑37 in regular lab bacteria. By attaching a special self‑cleaving tag, the peptide forms easy‑to‑collect clumps that can be spun down and released in pure form, giving about 0.6 mg of LL‑37 per litre of culture. The resulting peptide works as an antimicrobial, showing the method actually works.
Abstract
Antimicrobial peptides (AMPs) are part of the innate immune system of complex multicellular organisms. Despite the fact that AMPs show great potential as a novel class of antibiotics, the lack of a cost-effective means for their mass production limits both basic research and clinical use. In this work, we describe a novel expression system for the production of antimicrobial peptides in Escherichia coli by combining ΔI-CM mini-intein with the self-assembling amphipathic peptide 18A to drive the formation of active aggregates. Two AMPs, human β-defensin 2 and LL-37, were fused to the self-cleaving tag and expressed as active protein aggregates. The active aggregates were recovered by centrifugation and the intact antimicrobial peptides were released into solution by an intein-mediated cleavage reaction in cleaving buffer (phosphate-buffered saline supplemented with 40 mmol/L Bis-Tris, 2 mmol/L EDTA, pH 6.2). The peptides were further purified by cation-exchange chromatography. Peptides yields of 0.82 ± 0.24 and 0.59 ± 0.11 mg/L were achieved for human β-defensin 2 and LL-37, respectively, with demonstrated antimicrobial activity. Using our expression system, intact antimicrobial peptides were recovered by simple centrifugation from active protein aggregates after the intein-mediated cleavage reaction. Thus, we provide an economical and efficient way to produce intact antimicrobial peptides in E. coli.
Study Information
pubmed
2014
2014-01-07T00:00:00.000Z
10.1139/cjm-2013-0652
25
43